Truist maintains Buy on Axsome shares, reiterates $190 target
Truist Securities maintained a positive stance on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy rating and a $190.00 ...
Stifel raises Boston Scientific stock target to $120, keeps buy rating
Stifel analysts increased their price target on Boston Scientific Corporation (NYSE:BSX) shares from $115.00 to $120.00, while reiterating a Buy rating for the medical device company. The adjustment ...
Truist Financial Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP)
Truist Financial analyst Joon Lee maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today. The company’s shares closed ...
Truist Financial Reaffirms Their Buy Rating on IQVIA Holdings (IQV)
Truist Financial analyst Jailendra Singh reiterated a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of ...
American Banker5h
Will special bonuses for bank execs stir a hornet's nest?
Truist, KeyCorp and Goldman Sachs have granted one-time stock awards to certain executives they want to keep in place. One ...
Trump tariffs rip right through C-suites and financial models
GM produces highly profitable pickup trucks in Mexico and relies on plants there to make EVs such as the Chevy Blazer and ...